Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of CT-044 in Healthy Volunteers
NCT04252833Phase 1Completed
- Sponsor
- Lotus Clinical Research
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of CT-044 in acute pain and neuropathy, sponsored by Lotus Clinical Research. Primary endpoint: Maximum drug concentration at 7 days. Started Feb 2020; status: completed.
02
Drugs
CT-044
03
Conditions
acute painneuropathy
Beyond the preview
Go deeper on NCT04252833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252833.